Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 3/20 | 1.00 |
| ▸ | CES2 | O00748 | 2/20 | 0.83 |
| ▸ | CA1 | P00915 | 2/20 | 0.71 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.63 |
| ▸ | GSK3B | P49841 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1370034 | 0.91 | CES1 (1.00) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL2099160 | 0.89 | CES1 (0.79) | CES1CES2CA1CA2TDP1 | |
| Benzil SCHEMBL27888964 | 0.89 | CES1 (0.96) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL15180824 | 0.89 | CES1 (0.79) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL25250240 | 0.87 | CES1 (0.76) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL5200354 | 0.87 | CES1 (0.76) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL9486193 | 0.87 | CES1 (0.76) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL10517630 | 0.87 | CES1 (0.76) | CES1CES2CA1CA2TDP1 | |
| Cyanide SCHEMBL10981240 | 0.86 | CES1 (0.89) | CES1CES2CA1CA2TDP1 | |
| SCHEMBL975118 | 0.85 | SRD5A2 (0.83) | CES1CES2CA1CA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105884833-B | Preparation method and antitumor activity of novel ruthenium complex containing 4, 4 '-dibromo-2, 2' -bipyridyl | 江南大学 | 2020-05-08 | — | — | CN | claimed |
| JP-63213525-A | — | — | None | — | — | JP | disclosed |
| CN-119613344-A | High-efficiency photoinitiator, photosensitive composition and application | 武汉尚赛光电科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-11999700-B1 | [4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]acetic acid as an antimicrobial compound | King Faisal University (SA) | 2024-06-04 | — | — | US | disclosed |
| CN-117126043-A | Method for synthesizing benzil or derivative thereof by green oxidation of benzoin or derivative thereof | 常州大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-105884833-B | Preparation method and antitumor activity of novel ruthenium complex containing 4, 4 '-dibromo-2, 2' -bipyridyl | 江南大学 | 2020-05-08 | — | — | CN | disclosed |
| CN-105884835-A | Preparation method and antineoplastic activity of novel Ru(II) complex containing 4-nitrobenzene | 江南大学 | 2016-08-24 | — | — | CN | disclosed |
| US-20130123514-A1 | CARBOCATALYSTS FOR CHEMICAL TRANSFORMATIONS | GRAPHEA, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130123514-A1 | CARBOCATALYSTS FOR CHEMICAL TRANSFORMATIONS | GRAPHEA, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20110266945-A1 | DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-03 | — | — | US | disclosed |
| WO-2002083064-A2 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002083138-A1 | INHIBITORS OF AKT ACTIVITY | MERCK & CO., INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| EP-0739359-B1 | FREE RADICAL POLYMERISATION PROCESS | AVECIA LTD (GB) | 2000-03-22 | — | — | EP | disclosed |
| US-5770665-A | MOLECULAR WEIGHT CONTROL | ZENECA LIMITED (GB) | 1998-06-23 | — | — | US | disclosed |
| EP-0739359-A1 | FREE RADICAL POLYMERISATION PROCESS | ZENECA LIMITED (GB) | 1996-10-30 | — | — | EP | disclosed |
| WO-1995017435-A1 | FREE RADICAL POLYMERISATION PROCESS | ZENECA LIMITED (GB) | 1995-06-29 | — | — | WO | disclosed |
| EP-0304174-A2 | Bismaleimide compositions | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-02-22 | — | — | EP | disclosed |
| EP-0090493-B1 | PHOTOPOLYMERISABLE COMPOSITIONS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-02-08 | — | — | EP | disclosed |
| JP-S63213525-A | PRODUCTION OF POLYAMIDE RESIN | HITACHI CHEM CO LTD | 1988-09-06 | — | — | JP | disclosed |
| US-4602076-A | UNSATURATED MONOMER, KETONE, PEROXIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11999700-B1 | [4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]acetic acid as an antimicrobial compound | NANP, DPP4, NAAA | CES1 2859/4885CES2 3286/4885CA1 2806/4885 |
| US-20130123514-A1 | CARBOCATALYSTS FOR CHEMICAL TRANSFORMATIONS | TDO2, VIM, COMT | CES1 4294/4885CES2 2443/4885CA1 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.